文献速递糖尿病

美国女性循环催乳素浓度与2型糖尿病风险的前瞻性研究

Circulating prolactin concentrations and risk of type 2 diabetes in US women.
PubMed 文献 · Diabetologia · 2018-10-11

该研究基于护士健康研究(NHS)和NHSII队列,随访长达22年,在8615名基线无糖尿病和心血管疾病的女性中分析循环催乳素与2型糖尿病风险的关系。共记录699例新发2型糖尿病,总催乳素最高四分位组相比最低四分位组的多变量HR为0.73(95%CI 0.55-0.95;P趋势=0.02)。结论提示正常范围内较高的循环总催乳素与抽血后9-10年内较低的2型糖尿病风险相关。

要点

  • 正常范围内较高的总催乳素与较低2型糖尿病风险相关(HR 0.73,95%CI 0.55-0.95)。
  • 该负相关在抽血后前9年显著,随后随时间线性减弱。
  • 生物活性催乳素的负相关较总催乳素更强但差异无统计学意义(HR 0.53 vs 0.81,P差异=0.11)。

核心结论

  • 正常范围内较高的循环总催乳素浓度与美国女性抽血后9-10年内较低的2型糖尿病风险相关。
  • 研究结果与实验证据一致,提示健康女性中生物学正常范围内的催乳素可能在2型糖尿病发病中起保护作用。

研究设计与样本

  • 前瞻性队列研究,纳入护士健康研究(NHS)和NHSII中8615名基线无2型糖尿病和心血管疾病的女性,随访长达22年。
  • 基线血样采集时间:NHS 1989-1990年,NHSII 1996-1999年;998名NHS女性在2000-2002年提供第二次血样。
  • 总血浆催乳素用免疫分析法测定;生物活性催乳素在2478名女性子集中用Nb2生物分析法测定。
  • 采用Cox回归估计风险比(HR)。

主要发现

  • 随访156,140人年期间共记录699例新发2型糖尿病。
  • 总血浆催乳素水平与2型糖尿病风险呈负相关,最高与最低四分位比较的多变量HR为0.73(95%CI 0.55,0.95;P趋势=0.02)。
  • 按绝经状态和其他危险因素分层,关联相似(交互作用P>0.70)。
  • 额外调整性激素和生长激素、脂联素、炎症和胰岛素标志物未显著改变结果。
  • 在2478名女性子集中,生物活性催乳素与2型糖尿病风险的关联较总催乳素更强但无统计学显著性(极端四分位HR 0.53 vs 0.81,P差异=0.11)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Prolactin, a multifunctional hormone, is involved in regulating insulin sensitivity and glucose homeostasis in experimental studies. However, whether circulating concentrations of prolactin are associated with risk of type 2 diabetes remains uncertain. METHODS: We analysed the prospective relationship between circulating prolactin concentrations and type 2 diabetes risk in the Nurses' Health Study (NHS) and NHSII with up to 22 years of follow-up. Total plasma prolactin was measured using immunoassay in 8615 women free of type 2 diabetes and cardiovascular disease at baseline blood collection (NHS 1989-1990; NHSII 1996-1999) and a subset of 998 NHS women providing a second blood sample during 2000-2002. Baseline bioactive prolactin was measured in a subset of 2478 women using the Nb2 bioassay. HRs were estimated using Cox regression. RESULTS: A total of 699 incident type 2 diabetes cases were documented during 156,140 person-years of follow-up. Total plasma prolactin levels were inversely associated with type 2 diabetes risk; the multivariable HR comparing the highest with the lowest quartile was 0.73 (95% CI 0.55, 0.95; ptrend = 0.02). The associations were similar by menopausal status and other risk factors (pinteraction > 0.70). Additional adjustment for sex and growth hormones, adiponectin, and inflammatory and insulin markers did not significantly alter the results. The association of plasma bioactive prolactin with type 2 diabetes risk was non-significantly stronger than that of total prolactin (HR comparing extreme quartiles, 0.53 vs 0.81 among the subset of 2478 women, pdifference = 0.11). The inverse association of total prolactin with type 2 diabetes was significant during the first 9 years after blood draw but waned linearly with time, whereas for bioactive prolactin, the inverse relationship persisted for a longer follow-up time after blood draw. CONCLUSIONS/INTERPRETATION: A normally high circulating total prolactin concentration was associated with a lower type 2 diabetes risk within 9-10 years of follow-up since blood draw in US women. Our findings are consistent with experimental evidence, suggesting that among healthy women, prolactin within the biologically normal range may play a protective role in the pathogenesis of type 2 diabetes.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Li J, Rice MS, Huang T, et al. Circulating prolactin concentrations and risk of type 2 diabetes in US women. Diabetologia. 2018. PMID: 30306190. doi:10.1007/s00125-018-4733-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。